Sharon Benzeno serves as Executive at Adaptive Biotechnologies Corp, where they oversee executive responsibilities. Since joining the company, Sharon Benzeno has executed 111 insider transactions totaling $25.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 3, 2020 involved exercising options for 1,562 shares valued at $11.4K.
Sharon Benzeno currently holds 305,238 shares of Adaptive Biotechnologies Corp (ADPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sharon Benzeno has been a net seller of ADPT stock. They have purchased $0 and sold $25.1M worth of shares.
Sharon Benzeno's most recent insider trade was on Jun 3, 2020, when they sold 1,562 shares at $7.27 per share.
Get notified when new Form 4 filings are submitted
| $40.00 |
| Discretionary |
| May 26, 2020 | ADPT | $2.6K | Option Exercise | 416 | $6.32 | Discretionary |
| May 26, 2020 | ADPT | $17.5K | Sale | 416 | $42.00 | Discretionary |
| May 19, 2020 | ADPT | $324.1K | Option Exercise | 49,479 | $6.55 | Discretionary |
| May 19, 2020 | ADPT | $511.7K | Option Exercise | 78,125 | $6.55 | Discretionary |
| May 19, 2020 | ADPT | $96.7K | Option Exercise | 15,416 | $6.27 | Discretionary |
| May 19, 2020 | ADPT | $118.5K | Option Exercise | 18,750 | $6.32 | Discretionary |
| May 19, 2020 | ADPT | $118.8K | Option Exercise | 60,000 | $1.98 | Discretionary |
| May 19, 2020 | ADPT | $9.9M | Sale | 246,770 | $40.00 | Discretionary |
| May 19, 2020 | ADPT | $181.8K | Option Exercise | 25,000 | $7.27 | Discretionary |